摘要
Nataliya IMAEVA 医师
皮肤科医师
Lymphatic drainage and lifting techniques in botulinum toxin therapy: a new perspective on age-related correction
Objectives: To optimize botulinum toxin therapy protocols by integrating lymphatic drainage and lifting
Introduction: Traditionally, botulinum toxin therapy is associated with the relaxation of facial muscles to smooth wrinkles. However, modern anatomical research and clinical experience demonstrate that targeted botulinum toxin administration can influence not only facial expressions but also lymphatic drainage, while creating a lifting effect through redistribution of muscle tone. Ignoring the lymphatic component leads to incomplete correction of the edematous aging pattern and limits lifting outcomes.
Materials / method: • Lymphatic drainage methods: microdose injection of botulinum toxin type A per point into the superficial bundles of the lateral platysma muscle (the "lymphatic gate" area of the neck), as well as lifting techniques in patients with mobile ear canals and a single-belly fronto-occipital muscle. Photo and video treatments
Results: In patients with the deformational-edematous aging phenotype, the addition of lymphatic drainage techniques resulted in a reduction of morning edema in the lower eyelids, submental and preauricular areas. A pronounced effect of tissue volume reduction and lifting of the temporal region and lower third of the face was observed. Photos and videos of the procedures performed are presented.
Conclusion: 1. Botulinum toxin therapy can serve not only as a method for wrinkle relaxation but also as a tool for lymphatic drainage correction – provided that microdoses are injected into key muscular structures compressing the lymphatic pathways.
2. Lifting effects are achieved through modulation of muscle tension vectors, not through "filling" of tissues.
3. The proposed combination of techniques is safe, reproducible, and particularly indicated for patients with the deformational-edematous aging phenotype who have previously responded poorly to standard neuroprotein therapy.
披露 - Nataliya IMAEVA
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2026年 7月 30日 - Recorded during IMCAS Asia 2026